意大利胸部放射学专家建议:通过HRCT视觉评分量化进行性肺纤维化
意大利12名胸部放射科专家基于现有文献达成共识,提出针对进行性肺纤维化(PPF)患者HRCT视觉评估/评分的实践导向建议,涵盖HRCT准确评估的技术要求、常规临床可用的简易量化流程,以及结合影像、临床和病理的多学科方法,以正确诊断、及时识别PPF并启动抗纤维化治疗。
要点
- HRCT视觉评估需满足特定技术要求以保证准确评分。
- 共识提供了一套适用于常规临床实践的简易量化流程。
- 建议采用影像、临床与病理结合的多学科方法识别PPF。
核心结论
- 专家共识就可能量化肺纤维化的三个关键领域提出实践导向声明,以辅助放射科医生对PPF患者HRCT图像进行视觉评估/评分。
研究设计与样本
- 由12名意大利胸部放射科医生基于现有文献进行讨论,形成实践导向的共识声明。
诊断标准与关键数值
- 声明覆盖三个关键领域:准确评估HRCT图像所需的技术要求、常规临床实践中的简易量化流程、结合放射学临床和病理学表现的多学科方法。
临床应用与阅片要点
- 共识声明旨在辅助放射科医生对PPF患者HRCT图像进行视觉评估/评分。
- 采用结合放射学、临床和病理学表现的多学科方法以正确诊断、及时识别PPF并适时启动抗纤维化治疗。
- 未来自动化定量HRCT评估将带来新的临床评估工具。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Interstitial lung diseases (ILD) constitute a large and heterogeneous group of disorders affecting the lung parenchyma. While idiopathic pulmonary fibrosis (IPF), the most common type of ILD, is the prototype of progressive fibrosis, other forms, collectively termed "progressive pulmonary fibrosis" (PPF), can show a similar clinical course. Detecting chronic fibrosing ILD progression necessitates radiological evidence using high-resolution computed tomography (HRCT), which determines eligibility for treatment. However, assessing the extent of fibrosis and progression on HRCT images is difficult and lacks specific guidelines. Therefore, expert oversight and high-quality visual assessment/scoring of complex disease patterns is essential to monitor disease changes. Twelve Italian chest radiologists deliberated on the current state of quantifying lung fibrosis using existing literature to develop practice-oriented consensus statements to assist radiologists in visually assessing/scoring lung fibrosis on HRCT images in patients with PPF. The resulting statements cover three key areas: (1) technical requirements necessary for accurate HRCT image assessment; (2) an easy-to-use quantification protocol for routine clinical practice; and (3) a multiple specialist approach by combining radiological, clinical, and histopathological findings for the correct diagnosis, prompt detection of PPF, and timely start of antifibrotic treatment. In future, automated quantitative HRCT evaluation will lead to new clinical assessment tools.
引用
- Baratella E, Borghesi A, Calandriello L, et al. Quantification of progressive pulmonary fibrosis by visual scoring of HRCT images: recommendations from Italian chest radiology experts. Radiol Med. 2025. PMID: 40192924. doi:10.1007/s11547-025-01985-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。